shell play, page-9

It also depends on what comes in to the shell. Aptayl has spoken to the corporate advisor, who reckons TDX will probably remain in the bio-sciences, so resources may not happen. Also, it depends on the quality or risk of the company backed in. There have been two shells who have had companies backed in- can't remember the codes,but on news of the purchases, the companies went back to .001 (one purchased a kind of multi-level marketing company; the other some resource in Zimbabwe, of all places). Imagine how many companies and "assets" there are in the world, who would just love to be bought out: it doesn't mean they are necessarily good ones or wise choices. There are loads of ASX-listed companies where one can see the Directors have bought up something, get no sales of it, and live off Director fees from capital raisings. Not a bad life for them, probably. They can live a long time from ANN's that say they are in "discussions" regarding their products.